We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Reasons to Hold Trupanion (TRUP) Stock in Your Portfolio Now
Read MoreHide Full Article
Trupanion Inc.’s (TRUP - Free Report) focus on pets’ health and well-being in an underpenetrated pet insurance market, product innovations, geographical expansion and a solid capital position make it worth retaining in one’s portfolio.
Zacks Rank & Price Performance
Trupanion currently carries a Zacks Rank #3 (Hold).
In a month’s time, the stock has gained 10.2%, outperforming the industry’s increase of 3.2%.
Image Source: Zacks Investment Research
Growth Projections
The Zacks Consensus Estimate for 2023 earnings indicates an upside of 40.3% from the year-ago reported figure on 21.1% higher revenues.
The stock carries a favorable Growth Score of B. This style score analyzes the growth prospects of the company.
Business Tailwinds
This pet insurer operates in a large but underpenetrated market. With pet owners now focusing on pets’ health and well-being, TRUP, being a provider of insurance for cats and dogs, is poised for growth in a total addressable market of $38.1 billion.
The average pet now stays with Trupanion for 80 months, up from 78 months in the year-ago period, ensuring consistent revenue generation. The higher retention rates indicate customers’ fondness for TRUP’s products.
Trupanion stated that over the long term, companies that can invest in innovation and expand their addressable market are poised to be successful. Thus, TRUP launched low and medium ARPU products, Furkin and pet health insurance direct in Canada. TRUP intends to expand globally by entering Japan and Europe.
All these together should help TRUP achieve its target to grow subscription-adjusted operating income by 25% in 2022.
Trupanion remains focused on growing its addressable market by 40% by 2025 end by adding 10,000 international hospitals. This will increase its overall market from 25,000 in North America to 35,000 globally. This, in turn, should help TRUP expand its active hospital base.
Trupanion’s continuous new product development and international expansion are well supported by its solid financial position. These endeavors should help TRUP extend its moat and expand the addressable market in the long run. TRUP believes that if it can reach its five-year target. Its revenues may grow to more than $1.5 billion. TRUP may reach over 3.5 million pets and deliver growth in the intrinsic value of more than 25% per year.
MetLife’s earnings surpassed estimates in each of the last four quarters, the average beat being 42.9%.
The Zacks Consensus Estimate for MetLife’s 2022 and 2023 earnings has moved 0.5% and 0.4% north, respectively, in the past 30 days. In the past year, MET stock has gained 5.2%.
The Zacks Consensus Estimate for MGIC Investment’s 2022 and 2023 earnings has moved 1.8% and 3.2% north, respectively, in the past 30 days.
MTG’s earnings surpassed estimates in each of the last four quarters, the average beat being 10.94%. In the past year, MTG stock has lost 2.7%.
The Zacks Consensus Estimate for James River’s 2022 and 2023 earnings per share indicates year-over-year increases of 136% and 13.1%, respectively.
The Zacks Consensus Estimate for JRVR’s 2022 and 2023 earnings has moved 15.1% and 4.9% north, respectively, in the past 30 days. In the past year, JRVR stock has lost 28.1%.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Reasons to Hold Trupanion (TRUP) Stock in Your Portfolio Now
Trupanion Inc.’s (TRUP - Free Report) focus on pets’ health and well-being in an underpenetrated pet insurance market, product innovations, geographical expansion and a solid capital position make it worth retaining in one’s portfolio.
Zacks Rank & Price Performance
Trupanion currently carries a Zacks Rank #3 (Hold).
In a month’s time, the stock has gained 10.2%, outperforming the industry’s increase of 3.2%.
Image Source: Zacks Investment Research
Growth Projections
The Zacks Consensus Estimate for 2023 earnings indicates an upside of 40.3% from the year-ago reported figure on 21.1% higher revenues.
The stock carries a favorable Growth Score of B. This style score analyzes the growth prospects of the company.
Business Tailwinds
This pet insurer operates in a large but underpenetrated market. With pet owners now focusing on pets’ health and well-being, TRUP, being a provider of insurance for cats and dogs, is poised for growth in a total addressable market of $38.1 billion.
The average pet now stays with Trupanion for 80 months, up from 78 months in the year-ago period, ensuring consistent revenue generation. The higher retention rates indicate customers’ fondness for TRUP’s products.
Trupanion stated that over the long term, companies that can invest in innovation and expand their addressable market are poised to be successful. Thus, TRUP launched low and medium ARPU products, Furkin and pet health insurance direct in Canada. TRUP intends to expand globally by entering Japan and Europe.
All these together should help TRUP achieve its target to grow subscription-adjusted operating income by 25% in 2022.
Trupanion remains focused on growing its addressable market by 40% by 2025 end by adding 10,000 international hospitals. This will increase its overall market from 25,000 in North America to 35,000 globally. This, in turn, should help TRUP expand its active hospital base.
Trupanion’s continuous new product development and international expansion are well supported by its solid financial position. These endeavors should help TRUP extend its moat and expand the addressable market in the long run. TRUP believes that if it can reach its five-year target. Its revenues may grow to more than $1.5 billion. TRUP may reach over 3.5 million pets and deliver growth in the intrinsic value of more than 25% per year.
Stocks to Consider
Some better-ranked stocks from the insurance industry are MetLife, Inc. (MET - Free Report) , MGIC Investment Corporation (MTG - Free Report) and James River Group Holdings, Ltd. (JRVR - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
MetLife’s earnings surpassed estimates in each of the last four quarters, the average beat being 42.9%.
The Zacks Consensus Estimate for MetLife’s 2022 and 2023 earnings has moved 0.5% and 0.4% north, respectively, in the past 30 days. In the past year, MET stock has gained 5.2%.
The Zacks Consensus Estimate for MGIC Investment’s 2022 and 2023 earnings has moved 1.8% and 3.2% north, respectively, in the past 30 days.
MTG’s earnings surpassed estimates in each of the last four quarters, the average beat being 10.94%. In the past year, MTG stock has lost 2.7%.
The Zacks Consensus Estimate for James River’s 2022 and 2023 earnings per share indicates year-over-year increases of 136% and 13.1%, respectively.
The Zacks Consensus Estimate for JRVR’s 2022 and 2023 earnings has moved 15.1% and 4.9% north, respectively, in the past 30 days. In the past year, JRVR stock has lost 28.1%.